Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPTOMYCIN Cause Hepatic cytolysis? 151 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Hepatic cytolysis have been filed in association with DAPTOMYCIN (daptomycin). This represents 1.7% of all adverse event reports for DAPTOMYCIN.

151
Reports of Hepatic cytolysis with DAPTOMYCIN
1.7%
of all DAPTOMYCIN reports
6
Deaths
112
Hospitalizations

How Dangerous Is Hepatic cytolysis From DAPTOMYCIN?

Of the 151 reports, 6 (4.0%) resulted in death, 112 (74.2%) required hospitalization, and 2 (1.3%) were considered life-threatening.

Is Hepatic cytolysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 151 reports have been filed with the FAERS database.

What Other Side Effects Does DAPTOMYCIN Cause?

Off label use (791) Drug ineffective (658) Product use in unapproved indication (654) Eosinophilic pneumonia (575) Acute kidney injury (501) Blood creatine phosphokinase increased (461) Pyrexia (447) Eosinophilia (405) Rhabdomyolysis (383) Drug reaction with eosinophilia and systemic symptoms (307)

What Other Drugs Cause Hepatic cytolysis?

ACETAMINOPHEN (1,469) ATORVASTATIN (681) PEMBROLIZUMAB (601) CARBOPLATIN (577) METHOTREXATE (468) SULFAMETHOXAZOLE\TRIMETHOPRIM (356) PACLITAXEL (324) ENOXAPARIN (307) AMOXICILLIN (273) VALACYCLOVIR (261)

Which DAPTOMYCIN Alternatives Have Lower Hepatic cytolysis Risk?

DAPTOMYCIN vs DARATUMUMAB DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ DAPTOMYCIN vs DARBEPOETIN ALFA DAPTOMYCIN vs DARIDOREXANT DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE

Related Pages

DAPTOMYCIN Full Profile All Hepatic cytolysis Reports All Drugs Causing Hepatic cytolysis DAPTOMYCIN Demographics